Abstract
Psoriasis is a chronic inflammatory multi organ disease that affects 1–3 % of the general population. The etiology of psoriasis is not fully understood. It is considered a multifactorial disease that involves both genetic environmental influences. Among these factors, stress has been considered as an important role in the onset and exacerbation of psoriasis Heller (Skin Therapy Lett 16(5):1–4, 2011). Psychological stress may be also a consequence of psoriasis. Social stigmatization, rejection by the family and friends with consequent profound effect on self-confidence, self-image and sense of well being are most commonly seen in psoriasis patient. Psychiatric comorbidity in psoriasis patients is well documented in the literature. It is highly recommended that every patient of psoriasis should be thoroughly evaluated for the psychosocial percussions of the disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Weger W. Current status and new developments in the treatment of psoriasis and psoriatic arthritis with biological agents. Br J Pharmacol. 2010;160(4):810–20.
Rahman M, Alam K, Ahmad MZ, Gupta G, Afzal M, Akhter S, Kazmi I, Jyoti, Ahmad FJ, Anwar F. Classical to current approach for treatment of psoriasis: a review. Endocr Metab Immune Disord Drug Targets. 2012;12(3):287–302.
Ritchlin CT, Krueger JG. New therapies for psoriasis and psoriatic arthritis. Curr Opin Rheumatol. 2016;28(3):204–10.
Raychaudhuri SK, Maverakis E, Raychaudhuri SP. Diagnosis and classification of psoriasis. Autoimmun Rev. 2014;13(4–5):490–5. doi:10.1016/j.autrev.2014.01.008. Epub 2014 Jan 13.
Alexis AF, Blackcloud P. Psoriasis in skin of color: epidemiology, genetics, clinical presentation, and treatment nuances. Desai SR, Alexis A, eds. J Clin Aesthet Dermatol. 2014;7(11):16–24.
Sampogna F, Gisondi P, Melchi CF, Amerio P, Girolomoni G, Abeni D. Prevalence of symptoms experienced by patients with different clinical types of psoriasis. Br J Dermatol. 2004;151(3):594–9.
Heller MM, Lee ES, Koo JY. Stress as an influencing factor in psoriasis. Skin Therapy Lett. 2011;16(5):1–4.
Sathyanarayana Rao TS, Basavaraj KH, Das K. Psychosomatic paradigms in psoriasis: psoriasis, stress and mental health. Indian J Psychiatry. 2013;55(4):313–5.
Gupta MA, Gupta AK, Ellis CN, Voorhees JJ. Some psychosomatic aspects of psoriasis. Adv Dermatol. 1990;5:21–30.
Yosipovitch G, Tang M, Dawn AG, Chen M, Goh CL, Huak Y, Seng LF. Study of psychological stress, sebum production and acne vulgaris in adolescents. Acta Derm Venereol. 2007;87(2):135–9.
Arndt J, Smith N, Tausk F. Stress and atopic dermatitis. Curr Allergy Asthma Rep. 2008;8(4):312–7.
Chung MC, Symons C, Gilliam J, Kaminski ER. Stress, psychiatric co-morbidity and coping in patients with chronic idiopathic urticaria. Psychol Health. 2010;25(4):477–90.
Zachariae R, Zachariae H, Blomqvist K, Davidsson S, Molin L, Mørk C, Sigurgeirsson B. Self-reported stress reactivity and psoriasis-related stress of Nordic psoriasis sufferers. J Eur Acad Dermatol Venereol. 2004;18(1):27–36.
Verhoeven EW, Kraaimaat FW, Jong EM, Schalkwijk J, van de Kerkhof PC, Evers AW. Effect of daily stressors on psoriasis: a prospective study. J Invest Dermatol. 2009;129:2075–7.
Evers AW, Verhoeven EW, Kraaimaat FW, de Jong EM, de Brouwer SJ, Schalkwijk J, et al. How stress gets under the skin: cortisol and stress reactivity in psoriasis. Br J Dermatol. 2010;163(5):986–91.
Malhotra SK, Mehta V. Role of stressful life events in induction or exacerbation of psoriasis and chronic urticaria. Indian J Dermatol Venereol Leprol. 2008;74:594–9.
Moynihan J, Rieder E, Tausk F. Psychoneuroimmunology: the example of psoriasis. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia. 2010;145(2):221–8.
Elloso MM, Gomez-Angelats M, Fourie AM. Targeting the Th17 pathway in psoriasis. J Leukoc Biol. 2012;92(6):1187–97. doi:10.1189/jlb.0212101. Epub 2012 Sep 7.
Mease PJ. Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis. Curr Opin Rheumatol. 2015;27(2):127–33.
Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J, Ouyang W. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature. 2007;445(7128):648–51.
Brunoni AR, Santos IS, Sabbag C, Lotufo PA, Benseñor IM. Psoriasis severity and hypothalamic-pituitary-adrenal axis function: results from the CALIPSO study. Braz J Med Biol Res. 2014;47(12):1102–6.
Loite U, Kingo K, Reimann E, Reemann P, Vasar E, Silm H, Kõks S. Gene expression analysis of the corticotrophin-releasing hormone-proopiomelanocortin system in psoriasis skin biopsies. Acta Derm Venereol. 2013;93(4):400–5.
Richards HL, Ray DW, Kirby B, Mason D, Plant D, Main CJ, Fortune DG, Griffiths CE. Response of the hypothalamic-pituitary-adrenal axis to psychological stress in patients with psoriasis. Br J Dermatol. 2005;153(6):1114–20.
Karanikas E, Harsoulis F, Giouzepas I, Griveas I. Stimulation of the hypothalamic-pituitary-adrenal axis with corticotropin releasing hormone in patients with psoriasis. Hormones (Athens). 2007;6(4):314–20.
Kadam DP, Suryakar AN, Ankush RD, Kadam CY, Deshpande KH. Role of oxidative stress in various stages of psoriasis. Indian J Clin Biochem. 2010;25(4):388–92.
Attwa E, Swelam E. Relationship between smoking-induced oxidative stress and the clinical severity of psoriasis. J Eur Acad Dermatol Venereol. 2011;25(7):782–7.
Bakry OA, El Hefnawy S, Mariee AH, El Gendy Y. Urinary biopyrrins: a new marker of oxidative stress in psoriasis. Indian J Dermatol. 2016;61(2):169–73.
Sampogna F, Tabolli S, Abeni D. Living with psoriasis prevalence of shame, anger, worry and problems in daily activities and social life. Acta Derm Venereol. 2012;92:299–303.
Weiss SC, Kimball AB, Liewehr DJ, et al. Quantifying the harmful effects of psoriasis on health-related quality of life. J Am Acad Dermatol. 2002;47:512–8.
Kurd SK, Troxel AB, Critis-Christoph P, et al. The risk of depression, anxiety and suicidality in patients with psoriasis: a population based cohort study. Arch Dermatol. 2010;146:891–5.
Egeberg A, Hansen PR, Gislason GH, et al. Risk of self-harm and non-fatal suicide attempts, and completed suicide in patients with psoriasis – a population-based cohort study. Br J Dermatol. 2016. doi: 10.1111/bjd.14633 [Epub ahead of Print].
Kimball AB, Gieler U, Linder D, et al. Psoriasis: Is the impairment to a patient’s life cumulative? J Eur Acad Dermatol Venereol. 2010;24:989–1004.
Mizara A, Papadoupolos I, McBride SR. Core beliefs and psychological distress in patients with psoriasis and atopic eczema attending secondary care: the role of schemas in chronic skin disease. Br J Dermatol. 2012;166:986–93.
Devrimici-Ozguven H, Kundakci TN, Kumbasar H, et al. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol. 2000;14:267–71.
Kleyn CE, McKie S, Ross R, et al. Diminished neural and cognitive responses to facial expressions of disgust in patients with psoriasis: a functional magnetic resonance imaging study. J Invest Dermatol. 2009;129:2613–9.
Tee SI, Lim ZV, Theng CT, et al. A prospective cross sectional study of anxiety and depression in patients with psoriasis in Singapore. J Eur Acad Dermatol Venereol. 2016;30(7):1159–64. doi:10.1111/jdv13615.
Eghlileb AM, Davies EEG, Finlay AY. Psoriasis has a major secondary impact on the lives of family members and partners. Br J Dermatol. 2007;156:1245–50.
Gupta MA, Gupta AK. Psoriasis and sex: a study of moderately to severly affected patients. Int J Dermatol. 1997;36:259–62.
Sampogna F, Gisondi P, Tabolli S, et al. Impairment of sexual life in patients with psoriasis. Dermatology. 2007;214:144–50.
Goulding JM, Price CL, Defty CL, et al. Erectyl dysfunction in patients with psoriasis: increased prevalence, an unmet need, and a chance to intervene. Br J Dermatol. 2011;164:103–9.
Mills CM, Srivastava ED, Harvey IM. Smoking habits in psoriasis: a case controlled study. Br J Dermatol. 1992;127:18–21.
Gupta MA, Schork NJ, Gupta AK, et al. Alcohol intake and treatment responsiveness of psoriasis: a prospective study. J Am Acad Dermatol. 1993;28:730–2.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
França, K., Jafferany, M. (2017). Psoriasis. In: França, K., Jafferany, M. (eds) Stress and Skin Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-46352-0_21
Download citation
DOI: https://doi.org/10.1007/978-3-319-46352-0_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-46351-3
Online ISBN: 978-3-319-46352-0
eBook Packages: MedicineMedicine (R0)